LitAlert ~~ GeneLit.com

    • African American Women Need to Know More About High-Risk Breast Cancer.
    • Johnson F.
    • FORCE. Blog. 2022 May 2.
    • Clinical benefit of olaparib in Mexican ovarian cancer patients with founder mutation BRCA1-Del ex9-12.
    • Gallardo-Rincón D, Montes-Servín E, Alamilla-García G, Montes-Servín E, Bahena-González A, Cetina-Pérez L, Morales-Vásquez F, Cano-Blanco C, Coronel Martinez JA, González-Ibarra E, Espinoza-Romero R, Alvarez-Gómez RM, Pedroza-Torres A, Castro-Eguiluz D.
    • Front Genet. 2022 May 2;12:863956. doi: 10.3389/fgene.2022.863956.
    • Perceptions and Care Recommendations from Previvors: Qualitative Analysis of Female BRCA1/2 Mutation Carriers’ Experience with Genetic Testing and Counseling.
    • Dibble KE, Donorfio LKM, Britner PA, Bellizzi KM.
    • Gynecol Oncol Rep. 2022 May 2;100989. doi: 10.1016/j.gore.2022.100989.
    • BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.
    • Cremona M, Vandenberg CJ, Farrelly AM, Madden SF, Morgan C, Kalachand R, McAlpine JN, Toomey S, Huntsman DG, Grogan L, Breathnach O, Morris P, Carey MS, Scott CL, Hennessy BT.
    • Br J Cancer. 2022 Apr 30. doi: 10.1038/s41416-022-01823-5. Epub ahead of print.